Last reviewed · How we verify

NCT04747743

Usage of Skeletal Muscle Relaxants Survey Among Egyptian Dental Practitioners

Completed Last updated 27 May 2022
What this trial tests

trial testing a self structured questionnaire in Temporomandibular Joint Disorders in 170 participants. Completed in 15 March 2021.

Timeline
10 February 2021
Primary endpoint
10 March 2021
15 March 2021

Quick facts

Lead sponsorFuture University in Egypt
StatusCompleted
Study typeOBSERVATIONAL
Enrollment170
Start date10 February 2021
Primary completion10 March 2021
Estimated completion15 March 2021
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Future University in Egypt

Who can join

Adults 20 to 60, any sex, with Temporomandibular Joint Disorders or Bruxism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pharmacists may also logistically serve as ideal health-care destinations to implement and deliver prevention, early intervention, and referral of oral health services to reduce the incidence of potentially preventable oral conditions including tooth decay, gum disease, and oral cancer. Interprofessional teamwork between pharmacist and dentistry may help to encourage pharmacists to take a more active role in promoting oral health. By providing information and assistance for self-care and the use of over the counter (OTC) products for minor problems on oral health, it can provide better patient care in the Malaysian health-care system

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

Other Future University in Egypt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04747743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing